Mizuho analyst Ann Hynes lowered the firm’s price target on Elevance Health (ELV) to $505 from $585 and keeps an Outperform rating on the shares. The firm updated the company’s model post earnings.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Elevance Health price target lowered to $495 from $593 at Wells Fargo
- Elevance sues U.S. over Medicare star ratings, Bloomberg says
- Molina Healthcare price target raised to $345 from $335 at Stephens
- Medicare paid insurers approx $4.2B for home diagnoses, WSJ reports
- 3 Best Stocks to Buy Now, 10/24/2024, According to Top Analysts